60 Degrees Pharmaceuticals, Inc. SXTP
0.50 USD -0.04 (-7.05%)
Regular-session close
0.50 0.00 0.00%
After hours · Nov 19, 5:24 PM ET
0.50 Day range 0.5165
0.46 52-week range 8.62
- YTD
- -75.37%
- 1 year
- -88.10%
News
benzinga.com 60 Degrees Q3 EPS $(0.75) Misses $(0.73) Estimate, Sales $233.235K Miss $300.000K Estimate 60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.73) by 2.74 percent. This is a 71.8 percent increase over losses of $(2.66)…
defenseworld.net Critical Survey: GSK (NYSE:GSK) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP) GSK (NYSE: GSK - Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ: SXTP - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses…benzinga.com 60 Degrees Pharmaceutical Enters Sponsored Research Agreement With University Of Southern Mississippi To Assess The Potential Of Castanospermine In Nonclinical Models Of Alpha-Gal Syndrome The partnership leverages USM’s established vector biology research expertise and investigator insights into tick-borne disease. Under this agreement, 60 Degrees will underwrite the research and…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Axogen (NASDAQ:AXGN) stock rose 17.7% to $44.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q3 earnings report…benzinga.com 60 Degrees Pharma Reports Clinical, Molecular Results From First Five Completed Patients In Relapsing Babesiosis Expanded Access Study; All Five Completed Patients Report Clinical Improvement All five completed patients (100%) reported much or very much improved clinical outcomes and tested negative for Babesia on conventional PCR testsFour of five completed patients (80%) were negative…
